IP Verse

Silence Therapeutics competitive analysis

Latest publications and patents of Silence Therapeutics New

Explore the latest publications and patents granted to Silence Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Silence Therapeutics
EP3607069	Nov 2, 2022	Products And Compositions	Granted And Under Opposition
EP1857547	Dec 2, 2020	Further Novel Forms Of Interfering Rna Molecules	Patent Maintained As Amended
EP2258847	Jul 1, 2020	Futher Novel Forms Of Interfering Rna Molecules	Patent Maintained As Amended
EP3222724	Oct 31, 2018	Further Novel Forms Of Interfering Rna Molecules	Granted And Under Opposition

Latest oppositions filed by Silence Therapeutics

Explore patent oppositions filed by Silence Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2813582	Rna Interference Mediating Small Rna Molecules	EUROPISCHES LABORATORIUM FR MOLEKULARBIOLOGIE EMBL	Jan 12, 2018
EP1798285	Methods And Medicament For Inhibition The Expression Of A Defined Gene	ALNYLAM EUROPE	Dec 15, 2017

Latest patents of Silence Therapeutics opposed by its competitors

Explore Silence Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3607069	Nov 2, 2022	Products And Compositions	1
EP1857547	Dec 2, 2020	Further Novel Forms Of Interfering Rna Molecules	3
EP2258847	Jul 1, 2020	Futher Novel Forms Of Interfering Rna Molecules	3
EP3222724	Oct 31, 2018	Further Novel Forms Of Interfering Rna Molecules	1

Latest PTAB cases involving Silence Therapeutics

Discover the latest PTAB cases involving Silence Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Silence Therapeutics
PGR2018-00089	Jul 17, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00088	Jul 17, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00075	Jul 9, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00067	Jun 11, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00059	Apr 2, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled

Peer Comparison New

IP litigation analysis comparing Silence Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SILENCE THERAPEUTICS	2	8	-	5	Defensive
ALNYLAM PHARMACEUTICALS	4	4	5	-	Highly Aggressive
SANOFI	59	23	-	-	Highly Aggressive
THE MEDICINES UK	2	-	-	-	Highly Aggressive